For these reasons, recent investigations have expanded the focus to additional disease mechanisms
to enable you to receive information that may be of interest to you regarding our products/services, website, newsletter, promotional offers, direct marketing and competitions and to manage these activities
doi: 10.1186/s12891-022-05396-5 Summary Keywords type 2 diabetes, osteoporosis, GLP-1 receptor agonists, electronic medical records, cohort study, bone metabolism, fracture risk Citation Chen M, Lyu Y, Zhao J, Han X, Huang T, Yang T and Zhou Y (2025) Use of GLP-1 receptor agonist and risk of osteoporosis among patients with type 2 diabetes: a real-world study
C., Kleinman, W